Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Antimicrobial drugs for treating cholera
Y Leibovici‐Weissman, A Neuberger… - Cochrane Database …, 2014 - cochranelibrary.com
Background Cholera is an acute watery diarrhoea caused by infection with the bacterium
Vibrio cholerae, which if severe can cause rapid dehydration and death. Effective …
Vibrio cholerae, which if severe can cause rapid dehydration and death. Effective …
Resistance to the nitroheterocyclic drugs
SM Townson, PFL Boreham, P Upcroft, JA Upcroft - Acta tropica, 1994 - Elsevier
The nitroheterocyclic drugs have been available since the early 1960's for the treatment of
anaerobic protozoa. The application of these drugs has widened since then and they are …
anaerobic protozoa. The application of these drugs has widened since then and they are …
A review on nanomaterial-based electrodes for the electrochemical detection of chloramphenicol and furazolidone antibiotics
To grow food for people, antibiotics were used, and these antibiotics can accumulate in the
human body through food metabolism, which may have remarkably harmful effects on …
human body through food metabolism, which may have remarkably harmful effects on …
Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research
BH Ali - Veterinary Research Communications, 1999 - Springer
Some of the recent publications on the pharmacological, therapeutic and toxicological
properties of the antimicrobial agent furazolidone (FZ) are briefly reviewed. In animals, most …
properties of the antimicrobial agent furazolidone (FZ) are briefly reviewed. In animals, most …
Cholera: pathophysiology, clinical features, and treatment
ML Bennish - Vibrio cholerae and cholera: molecular to global …, 1994 - Wiley Online Library
This chapter reviews the pathophysiology of cholera, focusing on the most common and
important complication, dehydration; describes the clinical features of patients with cholera; …
important complication, dehydration; describes the clinical features of patients with cholera; …
Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139
WA Khan, ML Bennish, C Seas, EH Khan, A Ronan… - The Lancet, 1996 - thelancet.com
Background Effective antimicrobial therapy can reduce the duration and volume of cholera
diarrhoea by half. However, such treatment is currently limited by Vibrio cholerae resistance …
diarrhoea by half. However, such treatment is currently limited by Vibrio cholerae resistance …
Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis
C Ji, J Liu, Y Li, C Guo, J Qu, Y Zhang, X Zuo - BMJ open, 2020 - bmjopen.bmj.com
Objectives Furazolidone containing regimen is effectivefor Helicobacter pylori (H. pylori)
infection, but its safetyremains controversial. To assess the safety of furazolidone containing …
infection, but its safetyremains controversial. To assess the safety of furazolidone containing …
Solvothermal synthesis of carbon incorporated MnS2 Spheres; high sensing performance towards the detection of furazolidone in bio-fluids
Herein, we designed and synthesis a composite material consisting of manganese disulfide
anchored on nitrogen-doped carbon spheres (MnS 2@ N-CS) as an electrode modifier, and …
anchored on nitrogen-doped carbon spheres (MnS 2@ N-CS) as an electrode modifier, and …
Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial
Background Cholera is a major public-health problem, with children most affected. However,
effective single-dose antimicrobial regimens have been identified only for adults. Our aim …
effective single-dose antimicrobial regimens have been identified only for adults. Our aim …
The role of antibiotics in the treatment of infectious diarrhea
EC Oldfield, MR Wallace - Gastroenterology Clinics, 2001 - gastro.theclinics.com
Infectious diarrhea is one of the most common causes of morbidity and mortality in the world,
with an estimated 3 to 5 billion annual infections and 3 million deaths per year. 12 In the …
with an estimated 3 to 5 billion annual infections and 3 million deaths per year. 12 In the …